|
1
|
Owens GK, Kumar MS and Wamhoff BR:
Molecular regulation of vascular smooth muscle cell differentiation
in development and disease. Physiol Rev. 84:767–801. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Langheinrich AC and Bohle RM:
Atherosclerosis: Humoral and cellular factors of inflammation.
Virchows Arch. 446:101–111. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ross R: Atherosclerosis is an inflammatory
disease. Am Heart J. 138:S419–S420. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Berk BC, Vekshtein V, Gordon HM and Tsuda
T: Angiotensin II-stimulated protein synthesis in cultured vascular
smooth muscle cells. Hypertension. 13:305–314. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ji Y, Liu J, Wang Z and Liu N: Angiotensin
II induces inflammatory response partly via toll-like receptor
4-dependent signaling pathway in vascular smooth muscle cells. Cell
Physiol Biochem. 23:265–276. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rosati A, Graziano V, De Laurenzi V,
Pascale M and Turco MC: BAG3: A multifaceted protein that regulates
major cell pathways. Cell Death Dis. 2:e1412011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Suzuki M, Iwasaki M, Sugio A, Hishiya A,
Tanaka R, Endo T, Takayama S and Saito T: BAG3 (BCL2-associated
athanogene 3) interacts with MMP-2 to positively regulate invasion
by ovarian carcinoma cells. Cancer Lett. 303:65–71. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kassis JN, Guancial EA, Doong H, Virador V
and Kohn EC: CAIR-1/BAG-3 modulates cell adhesion and migration by
downregulating activity of focal adhesion proteins. Exp Cell Res.
312:2962–2971. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Homma S, Iwasaki M, Shelton GD, Engvall E,
Reed JC and Takayama S: BAG3 deficiency results in fulminant
myopathy and early lethality. Am J Pathol. 169:761–773. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chami N, Tadros R, Lemarbre F, Lo KS,
Beaudoin M, Robb L, Labuda D, Tardif JC, Racine N, Talajic M and
Lettre G: Nonsense mutations in BAG3 are associated with
early-onset dilated cardiomyopathy in French Canadians. Can J
Cardiol. 30:1655–1661. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
D'Avenia M, Citro R, De Marco M, Veronese
A, Rosati A, Visone R, Leptidis S, Philippen L, Vitale G, Cavallo
A, et al: A novel miR-371a-5p-mediated pathway, leading to BAG3
upregulation in cardiomyocytes in response to epinephrine, is lost
in Takotsubo cardiomyopathy. Cell Death Dis. 6:e19482015.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Xiao F, Puddefoot JR, Barker S and Vinson
GP: Mechanism for aldosterone potentiation of angiotensin
II-stimulated rat arterial smooth muscle cell proliferation.
Hypertension. 44:340–345. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wu C, Lv C, Chen F, Ma X, Shao Y and Wang
Q: The function of miR-199a-5p/Klotho regulating TLR4/NF-κB
p65/NGAL pathways in rat mesangial cells cultured with high glucose
and the mechanism. Mol Cell Endocrinol. 417:84–93. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Du F, Li S, Wang T, Zhang HY, Li DT, Du
ZX, Wang HQ and Wang YQ: BAG3 regulates ECM accumulation in renal
proximal tubular cells induced by TGF-β1. Am J Transl Res.
7:2805–2814. 2015.PubMed/NCBI
|
|
16
|
Shi H, Xu H, Li Z, Zhen Y, Wang B, Huo S,
Xiao R and Xu Z: BAG3 regulates cell proliferation, migration, and
invasion in human colorectal cancer. Tumour Biol. 37:5591–5597.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kong DH, Li S, Du ZX, Liu C, Liu BQ, Li C,
Zong ZH and Wang HQ: BAG3 elevation inhibits cell proliferation via
direct interaction with G6PD in hepatocellular carcinomas.
Oncotarget. 7:700–711. 2016.PubMed/NCBI
|
|
18
|
Zhu H, Liu P and Li J: BAG3: A new
therapeutic target of human cancers? Histol Histopathol.
27:257–261. 2012.PubMed/NCBI
|
|
19
|
Du F, Li S, Wang T, Zhang HY, Li DT, Du ZX
and Wang HQ: Implication of Bcl-2-associated athanogene 3 in
fibroblast growth factor-2-mediated epithelial-mesenchymal
transition in renal epithelial cells. Exp Biol Med (Maywood).
240:566–575. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Feldman AM, Begay RL, Knezevic T, Myers
VD, Slavov DB, Zhu W, Gowan K, Graw SL, Jones KL, Tilley DG, et al:
Decreased levels of BAG3 in a family with a rare variant and in
idiopathic dilated cardiomyopathy. J Cell Physiol. 229:1697–1702.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
De Marco M, D'Auria R, Rosati A, Vitulano
G, Gigantino A, Citro R, Piscione F, Zilinski J, Januzzi JL Jr and
Turco MC: BAG3 protein in advanced-stage heart failure. JACC Heart
Fail. 2:673–675. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Feldman AM, Gordon J, Wang J, Song J,
Zhang XQ, Myers VD, Tilley DG, Gao E, Hoffman NE, Tomar D, et al:
BAG3 regulates contractility and Ca(2+) homeostasis in adult mouse
ventricular myocytes. J Mol Cell Cardiol. 92:10–20. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jeong IK, Oh DH, Park SJ, Kang JH, Kim S,
Lee MS, Kim MJ, Hwang YC, Ahn KJ, Chung HY, et al: Inhibition of
NF-κB prevents high glucose-induced proliferation and plasminogen
activator inhibitor-1 expression in vascular smooth muscle cells.
Exp Mol Med. 43:684–692. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Rapino F, Abhari BA, Jung M and Fulda S:
NIK is required for NF-κB-mediated induction of BAG3 upon
inhibition of constitutive protein degradation pathways. Cell Death
Dis. 6:e16922015. View Article : Google Scholar : PubMed/NCBI
|
